Skip to main content

Romantic Love Affects Your Brain Like a Drug





Study Shows a Link Between Intense Feelings of Love and Reward Areas of the Brain






The euphoric “high” that accompanies the passion-filled, early days of romantic love is a common pop music theme, but is it just a metaphor or is love really like a drug?

When researchers examined the question, they found that intense feelings of romantic love affect the brain in the same way drugs like cocaine or powerful pain relievers do.

“The reason people are so attracted to cocaine is that it activates the area of the brain that makes you feel good,” researcher Arthur Aron, PhD, tells WebMD. “The same reward area is activated when people are experiencing the intense desire of romantic love.”

Intense Love = Less Pain

Aron, who is a professor of psychology at State University of New York (SUNY) Stony Brook, has been researching the impact of love on the brain for three decades.

Several years ago he and longtime pain researcher Sean Mackey, MD, PhD, began talking at a neuroscience conference and conceived the idea for the study.

Mackey is chief of the division of pain management and an associate professor of anesthesia at Stanford University Medical Center in California.

“He was talking about the neural systems involved with love and I was talking about the neural systems involved with pain, and we realized there was a lot of overlap,” Mackey says.

They recruited couples in the first few months of romantic relationships for the study by posting notices around Stanford University. The researchers specifically focused on the euphoric, obsessive phase of early love rather than more mature romantic relationships.

“Our subjects fit into this category of recklessly, widely, passionately in love, and it was the easiest recruiting we ever did,” Mackey tells WebMD. “The fliers asked ‘Are you in love?' and within hours we had a dozen couples beating on our doors.”

The hypothesis was that love affected the brain in the same way many addictive drugs do, by targeting the “feel good” chemical in the brain known as dopamine. This reward system has also been shown to be critical in pain management.

Targeted Pain Treatments

The study included eight female and seven male students who were asked to bring photographs of their loved one to the lab along with photos of an equally attractive friend of the same sex as their romantic interest.

MRI scans recorded what was happening in their brains as they viewed the pictures while holding in their hands a computer-controlled thermal device that got increasingly hotter as the experiment progressed.

Throughout the experiment, the participants were asked to record the pain they felt from the device on a scale of 0 to 10, with 0 representing “no pain” and 10 representing “the worst pain imaginable.”

Because distraction has been shown to affect pain, one phase of the experiment involved distracting the participants by asking them questions that had nothing to do with the study.

The brain imaging showed that both love and distraction reduced pain, but in different ways.

When distracted, the brain pathway affecting the sensation of pain was mostly centered in the higher, cortical part of the brain, while the impact of love was on the brain's dopamine-related reward center.

The study appeared online on Oct. 13, 2010 in the publication PLoS One.

Aron and Mackey agree the findings show the potential for more targeted approaches to pain relieve that may or may not involve drugs.

Mackey says the way we manage pain today will be considered the Dark Ages by future generations.

“Right now we use antidepressants, antiseizure drugs, and cardiac arrhythmia drugs to treat pain in patients who don't have seizures or arrhythmias and may not even be depressed,” he says. “The hope is that in the future we will develop targeted treatments that specifically address the abnormal neural systems involved in pain.”

Source: Rxlist.com

Comments

Popular posts from this blog

Final lunar eclipse of 2010 set for early morning of December 21

Skygazers hoping to catch the last lunar eclipse of 2010 on Tuesday morning best be ready to stay up late (or wake up very early) to watch the full moon as it goes through a range of dramatic color changes. The December 21 lunar eclipse is expected to last about three-and-a-half hours from its start as a partial eclipse at 1:33 a.m. ET to its finish at 5:01 a.m. ET, according to NASA. The previous lunar eclipse occurred June 26 . During a lunar eclipse, the moon, the Earth, and the sun align so that the sun's rays are shielded from the moon. An eclipse of the moon can only take place if the moon is full, and only if the moon passes through some portion of Earth's shadow, which is composed of two cone-shaped parts, one nested inside the other. The start of the total eclipse is expected around 2:41 a.m, when the entire moon passes through the Earth's umbra, or inner shadow, which blocks all direct sunlight from reaching the moon. The moon will tak...

Hand, Foot and Mouth Disease (HFMD) and Onychomadesis

  Introduction Nails are underutilized as diagnostic tools, despite being involved in many dermatologic conditions. This paper explores new concepts in the treatment of median nail dystrophy (MND), onychomycosis, and the nail pathology of hand, foot, and mouth disease (HFMD). A Pubmed database literature search was conducted for MND treatment, onychomycosis treatment, and HFMD nail pathology. Only papers published after January 2008 were reviewed. The results showed that 0.1% tacrolimus ointment can be an effective treatment for MND. Early studies on laser therapy indicate that it is a safe and efficacious treatment option for onychomycosis, compared to conventional oral antifungal agents. Vicks VapoRub (The Proctor & Gamble Company, Cincinnati, OH) is effective against onychomycosis and is a reasonable option in patients who choose to forgo conventional treatments. Lastly, there is evidence to support a correlation between HFMD and onychomadesis. ...

Men With Breast Cancer Face Worse Prognosis

Men who are diagnosed with breast cancer are more likely than female patients to die in the next 15 years, researchers report. "This may be due to a difference in tumor characteristics and treatment," says study leader Hui Miao, a PhD candidate at the National University of Singapore. Male breast cancer is rare, accounting for less than 1% of all breast cancers in the U.S. Given its scarcity, few studies have assessed its prognosis "and we know of no recent studies looking at trends in survival," Miao tells WebMD. So Miao and colleagues studied 459,846 women and 2,664 men diagnosed with breast cancer in Denmark, Finland, Switzerland, Norway, Singapore, and Sweden between 1970 and 2007. Among the findings, presented at the San Antonio Breast Cancer Symposium: Men were diagnosed at an older age: 69 vs. 61 for women. Twice as many men had later stage III or IV disease: 18% vs. 9% of women. Only 25% of men were alive 15 years after diagnosis, compared with 44...